{{Rsnum
|rsid=11228565
|Chromosome=11
|position=69211113
|Orientation=plus
|GMAF=0.1226
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 5.3 | 38.9 | 55.8
| HCB | 0.0 | 10.2 | 89.8
| JPT | 0.0 | 6.2 | 93.8
| YRI | 0.0 | 11.6 | 88.4
| ASW | 1.8 | 26.3 | 71.9
| CHB | 0.0 | 10.2 | 89.8
| CHD | 0.0 | 11.9 | 88.1
| GIH | 3.0 | 28.7 | 68.3
| LWK | 0.9 | 14.5 | 84.5
| MEX | 1.7 | 25.9 | 72.4
| MKK | 2.6 | 23.5 | 73.9
| TSI | 7.9 | 30.7 | 61.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=19767754
|Title=Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility
|OA=1
}}

{{omim
|id=611958
|rsnum=11228565
}}

{{PMID Auto
|PMID=22077888
|Title=Association of prostate cancer risk alleles with unfavourable pathological characteristics in potential candidates for active surveillance.
}}

{{PMID Auto
|PMID=22468268
|Title=Comprehensive resequence analysis of a 123-kb region of chromosome 11q13 associated with prostate cancer.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs11228565
|overall_frequency_n=14
|overall_frequency_d=128
|overall_frequency=0.109375
|n_genomes=11
|n_genomes_annotated=0
|n_haplomes=15
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{PMID Auto
|PMID=24037955
|Title=The presence of prostate cancer at biopsy is predicted by a number of genetic variants
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}